Uroboros Technologies LLC
DNA particles that spread out and grip cells
This article was originally published in Start Up
Biotechnology companies almost always talk about the precise molecular targets their drugs are intended to hit. But targets per se aren’t seen as particularly important at Uroboros Technologies LLC, which aims to turn DNA nanoparticles into cancer therapeutics. Rather than pursue defined targets, the San Diego-based start-up just wants to find particles that bind to cancer cells and not to normal ones.